CP-481,715 Nickel Allergy Study.
NCT00141180 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2006-07-25
Summary
To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.
Conditions
- Dermatitis, Allergic Contact
Interventions
- DRUG
-
CP-481,715
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-30
- Completion
- 2005-10-31
Countries
- United States
- Denmark
Study Locations
More Related Trials
-
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
NCT00868842 ·Status: COMPLETED
-
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
NCT06406114 ·Status: RECRUITING ·Phase: PHASE2
-
Short Repeated Nickel Exposures
NCT03309215 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria
NCT01170949 ·Status: TERMINATED ·Phase: PHASE2
-
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers
NCT03625219 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
NCT01489514 ·Status: COMPLETED
-
Clinical Evaluation of Metal Panel Allergens: Dose Response Study
NCT02615249 ·Status: COMPLETED ·Phase: PHASE2
-
Cold Contact Urticaria Treatment With Rilonacept
NCT02171416 ·Status: COMPLETED ·Phase: PHASE2
-
Quaternium-15, Use Test
NCT00311454 ·Status: UNKNOWN ·Phase: PHASE4
-
A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria
NCT04548869 ·Status: COMPLETED ·Phase: PHASE1
-
Etanercept for the Treatment of Chronic Urticaria
NCT01030120 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
NCT04438135 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1
-
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
NCT02117752 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting
NCT06532448 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare
NCT05580042 ·Status: COMPLETED ·Phase: PHASE1
-
Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
NCT01074840 ·Status: COMPLETED ·Phase: NA
-
Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin
NCT00363688 ·Status: TERMINATED ·Phase: PHASE4
-
Contact Allergy to Rubber Accelerators - a Clinical Study
NCT06042309 ·Status: COMPLETED ·Phase: NA
-
Drug Challenges Without Prior Skin Testing
NCT03158831 ·Status: COMPLETED ·Phase: PHASE1
-
Xerotic Dermatitis in Aged People
NCT01806935 ·Status: COMPLETED ·Phase: NA
-
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
NCT00104390 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge
NCT04454229 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1